Rigel: Q3 Earnings Snapshot
SOUTH SAN FRANCISCO, Calif. (AP) _ Rigel Pharmaceuticals Inc. (RIGL) on Thursday reported a loss of $19 million in its third quarter. The South San...
SOUTH SAN FRANCISCO, Calif. (AP) _ Rigel Pharmaceuticals Inc. (RIGL) on Thursday reported a loss of $19 million in its third quarter. The South San Francisco, California-based company said it had a loss of 11 cents per share. The results beat Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 13 cents per share. The drug developer posted revenue of $22.4 million in the period, missing Street forecasts. Four analysts surveyed by Zacks expected $22.